Aspirin and Extended – Release Dipyridamole Capsules, 25 mg / 200 mg (Par Pharmaceutical, Inc.)


Welcome to the PulseAid listing for the Aspirin and Extended – Release Dipyridamole Capsules, 25 mg / 200 mg drug offered from Par Pharmaceutical, Inc.. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical, Inc.
NON-PROPRIETARY NAME: Aspirin and Extended – Release Dipyridamole
SUBSTANCE NAME: ASPIRIN; DIPYRIDAMOLE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-01-30
END MARKETING DATE: 0000-00-00


Aspirin and Extended – Release Dipyridamole Capsules, 25 mg / 200 mg HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAspirin and Extended – Release Dipyridamole Capsules, 25 mg / 200 mg from Par Pharmaceutical, Inc.
LABELER NAME: Par Pharmaceutical, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25; 200(mg/1; mg/1)
START MARKETING DATE: 2017-01-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49884-007_bfa0e7a7-973f-4a42-ab00-2c2a2382020e
PRODUCT NDC: 49884-007
APPLICATION NUMBER: ANDA207944

Other ASPIRIN; DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingAspirin and Extended-Release Dipyridamole
Amneal Pharmaceuticals LLCAspirin and Extended-Release Dipyridamole
AvKARE, Inc.Aspirin and Extended-Release Dipyridamole
Boehringer Ingelheim Pharmaceuticals, Inc.Aggrenox
Carilion Materials ManagementAggrenox
Impax Genericsaspirin and dipyridamole
Par Pharmaceutical, Inc.Aspirin and Extended – Release Dipyridamole Capsules, 25 mg / 200 mg
Physicians Total Care, Inc.Aggrenox
Rebel Distributors Corp.Aggrenox
Roxane Laboratories, Inc.aspirin and dipyridamole
Teva Pharmaceuticals USA, Inc.Aspirin and Dipyridamole